Tempus AI
IPOIt's About Time
Public · Chicago, United States · Founded 2015 · $760.0M raised
- Headquarters
- Chicago, Illinois
- Employees
- 1001–5000
- Founded
- 2015
- Business Model
- B2B
- Total Funding
- $760.0M
- Last Round
- $200.0M Series G+Oct 2021
- Rounds
- 6
- Type
- Public
About
Tempus AI is a health technology company that applies artificial intelligence to genomic, clinical, and molecular data to enable precision medicine across oncology, neurology, cardiology, and radiology. Its platform includes genomic profiling, AI-powered diagnostics, real-world data products, and clinical trial matching for both healthcare providers and life sciences companies. Founded in 2015 by Eric Lefkofsky, Tempus went public on Nasdaq in 2024.
Summary
Tempus AI is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $760.0M in total across 6 rounds, most recently a $200.0M Series G+ round in Oct 2021. Investors include Baillie Gifford, Franklin Templeton and Google.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 7 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI cloud platform delivering full-stack infrastructure for model training, inference, and deploym...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...

UiPath is an AI-enhanced end-to-end automation platform.
GPU cloud infrastructure provider purpose-built for AI workloads and high-performance computing

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
